Summary & Overview
CPT 81459: Genomic Sequencing Procedures and Molecular Multianalyte Assays
CPT code 81459 represents genomic sequencing procedures and other molecular multianalyte assays, a cornerstone of modern molecular pathology and precision medicine. This code is widely used in laboratory settings to analyze genetic material, enabling clinicians to detect genetic anomalies, assess disease susceptibility, and inform targeted therapies. The national relevance of 81459 continues to grow as genomic testing becomes integral to patient care across specialties such as pathology, family medicine, and internal medicine.
Key payers covered in this publication include Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare. Readers will gain insights into payer coverage policies, clinical indications, and billing practices associated with 81459. The summary also addresses common modifiers, associated taxonomies, and relevant ICD-10 diagnoses, providing a comprehensive overview of the code's clinical and administrative context.
This publication offers benchmarks, policy updates, and a clear understanding of how 81459 fits into the broader landscape of molecular diagnostics. It is designed for healthcare professionals, billing specialists, and policy analysts seeking up-to-date information on genomic sequencing procedures and their impact on patient care and reimbursement.
CPT Code Overview
CPT code 81459 is used for genomic sequencing procedures and other molecular multianalyte assays. This code covers advanced molecular pathology and genomic testing services, which play a critical role in identifying genetic variations and guiding clinical decision-making. The typical site of service for these procedures is a laboratory setting, specifically place of service 81. These tests are essential for screening, diagnosis, and management of various genetic and chromosomal conditions, supporting precision medicine approaches across multiple specialties.
Clinical & Coding Specifications
Clinical Context
A patient presents to their primary care provider or cardiologist with a family history of cardiovascular disease or a personal history of acute myocardial infarction. The provider orders genomic sequencing procedures to assess genetic susceptibility to heart disease or to screen for chromosomal anomalies. The specimen is collected and sent to a laboratory (Place of Service 81), where molecular multianalyte assays are performed using CPT code 81459. The results may inform long-term drug therapy decisions or guide further management of atherosclerotic heart disease.
Coding Specifications
-
Modifier
26: Used when only the professional component (interpretation of results) is billed, typically by a pathologist or physician. -
Modifier
91: Used when the same clinical diagnostic laboratory test is repeated on the same patient, often to monitor changes or confirm results.
| Provider Taxonomy Code | Specialty Description |
|---|---|
207ZP0213X | Pathology - Clinical Pathology/Laboratory Medicine |